Annual ROE:
81.65%+101.32%(+515.10%)Summary
- As of today, ADMA annual return on equity is 81.65%, with the most recent change of +101.32% (+515.10%) on December 31, 2024.
- During the last 3 years, ADMA annual ROE has risen by +144.11% (+230.72%).
- ADMA annual ROE is now -98.81% below its all-time high of 6833.33%, reached on June 1, 2010.
Performance
ADMA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
67.79%-11.96%(-15.00%)Summary
- As of today, ADMA quarterly return on equity is 67.79%, with the most recent change of -11.96% (-15.00%) on June 30, 2025.
- Over the past year, ADMA quarterly ROE has increased by +45.36% (+202.23%).
- ADMA quarterly ROE is now -99.05% below its all-time high of 7100.00%, reached on September 30, 2010.
Performance
ADMA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ADMA ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | +515.1% | +202.2% |
3Y3 Years | +230.7% | +210.7% |
5Y5 Years | +138.9% | +162.3% |
ADMA ROE Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | at high | +230.7% | -27.4% | +212.9% |
5Y | 5-Year | at high | +138.9% | -27.4% | +162.2% |
All-Time | All-Time | -98.8% | +105.3% | -99.0% | +104.3% |
ADMA ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | 67.79%(-15.0%) |
Mar 2025 | - | 79.75%(-14.6%) |
Dec 2024 | 81.65%(+515.1%) | 93.41%(+135.9%) |
Sep 2024 | - | 39.59%(+76.5%) |
Jun 2024 | - | 22.43%(+1000.8%) |
Mar 2024 | - | -2.49%(+87.1%) |
Dec 2023 | -19.67%(+56.3%) | -19.31%(-17.8%) |
Sep 2023 | - | -16.39%(+46.4%) |
Jun 2023 | - | -30.56%(+18.0%) |
Mar 2023 | - | -37.29%(+28.2%) |
Dec 2022 | -44.96%(+28.0%) | -51.90%(+13.6%) |
Sep 2022 | - | -60.04%(+2.0%) |
Jun 2022 | - | -61.26%(+6.9%) |
Mar 2022 | - | -65.78%(-2.1%) |
Dec 2021 | -62.46%(+52.8%) | -64.40%(+15.8%) |
Sep 2021 | - | -76.47%(+4.3%) |
Jun 2021 | - | -79.91%(+4.9%) |
Mar 2021 | - | -84.07%(+20.3%) |
Dec 2020 | -132.38%(+37.0%) | -105.49%(+3.2%) |
Sep 2020 | - | -109.00%(-0.2%) |
Jun 2020 | - | -108.74%(+13.9%) |
Mar 2020 | - | -126.30%(+27.3%) |
Dec 2019 | -210.08%(+4.0%) | -173.63%(+6.6%) |
Sep 2019 | - | -185.81%(-3.6%) |
Jun 2019 | - | -179.42%(+16.6%) |
Mar 2019 | - | -215.05%(-12.6%) |
Dec 2018 | -218.77%(+10.3%) | -191.01%(-4.1%) |
Sep 2018 | - | -183.55%(+5.9%) |
Jun 2018 | - | -194.99%(+33.9%) |
Mar 2018 | - | -295.07%(+11.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | -243.95%(-155.7%) | -332.56%(+52.4%) |
Sep 2017 | - | -698.14%(+7.4%) |
Jun 2017 | - | -753.64%(-200.6%) |
Mar 2017 | - | 748.88%(-61.0%) |
Dec 2016 | 437.83%(+183.2%) | 1921.44%(+220.6%) |
Sep 2016 | - | -1593.72%(-148.0%) |
Jun 2016 | - | -642.66%(-71.5%) |
Mar 2016 | - | -374.80%(-44.7%) |
Dec 2015 | -526.24%(-331.7%) | -258.98%(-31.8%) |
Sep 2015 | - | -196.56%(-30.3%) |
Jun 2015 | - | -150.80%(-18.2%) |
Mar 2015 | - | -127.57%(+1.3%) |
Dec 2014 | -121.91%(-21.7%) | -129.27%(+16.0%) |
Sep 2014 | - | -153.98%(+9.4%) |
Jun 2014 | - | -169.93%(+16.2%) |
Mar 2014 | - | -202.69%(-0.2%) |
Dec 2013 | -100.18%(+32.7%) | -202.23%(+12.1%) |
Sep 2013 | - | -230.05%(-47.9%) |
Jun 2013 | - | -155.59%(-81.0%) |
Mar 2013 | - | -85.98%(-51.4%) |
Dec 2012 | -148.86%(+90.3%) | -56.78%(-18.0%) |
Sep 2012 | - | -48.11%(-305.3%) |
Jun 2012 | - | -11.87%(-213.2%) |
Mar 2012 | - | -3.79%(+99.5%) |
Dec 2011 | -1530.20%(-1110.2%) | - |
Mar 2011 | - | -796.43%(-135.9%) |
Dec 2010 | 151.47%(-97.8%) | 2220.00%(-68.7%) |
Sep 2010 | - | 7100.00%(+27.5%) |
Jun 2010 | - | 5566.67% |
Jun 2010 | 6833.33% | - |
FAQ
- What is ADMA Biologics, Inc. annual return on equity?
- What is the all-time high annual ROE for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual ROE year-on-year change?
- What is ADMA Biologics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly ROE year-on-year change?
What is ADMA Biologics, Inc. annual return on equity?
The current annual ROE of ADMA is 81.65%
What is the all-time high annual ROE for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual return on equity is 6833.33%
What is ADMA Biologics, Inc. annual ROE year-on-year change?
Over the past year, ADMA annual return on equity has changed by +101.32% (+515.10%)
What is ADMA Biologics, Inc. quarterly return on equity?
The current quarterly ROE of ADMA is 67.79%
What is the all-time high quarterly ROE for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly return on equity is 7100.00%
What is ADMA Biologics, Inc. quarterly ROE year-on-year change?
Over the past year, ADMA quarterly return on equity has changed by +45.36% (+202.23%)